Company coverage
Research snapshot 2026-08-31
Research activity
LMND 63 trade records · 0 option records · 2025-10-10 → 2026-05-07Moat
NarrowLemonade's claimed moat rests on proprietary AI claims processing that reduces costs and improves accuracy by ~30%. However, this technological advantage faces erosion as major incumbent insurers aggressively adopt AI. Switching costs are relatively…
Physical assets
MinimalPure software/platform company with no significant physical manufacturing, real estate, or tangible infrastructure. Asset-light is a strategic advantage operationally but provides no physical defensibility.
Software / hardware
Software100%
Hardware0%
Growth. AI claims processing cost advantage drives EBITDA profitability by Q4 2026 as car, home, pet, and life insurance lines compound 30% IFP growth. Primary assets. AI insurance underwriting platform, car/home/pet/life insurance licenses, mobile…
- manual · sw-hw
Growth. AI claims processing cost advantage drives EBITDA profitability by Q4 2026 as car, home, pet, and life insurance lines compound 30% IFP growth. Primary assets. AI insurance underwriting platform, car/home/pet/life insuran…
- manual · physical-assets
Pure software/platform company with no significant physical manufacturing, real estate, or tangible infrastructure. Asset-light is a strategic advantage operationally but provides no physical defensibility.
- manual · moat
Lemonade's claimed moat rests on proprietary AI claims processing that reduces costs and improves accuracy by ~30%. However, this technological advantage faces erosion as major incumbent insurers aggressively adopt AI. Switching…
| Date | Action | Type | Relative size |
|---|---|---|---|
| 2026-05-07 | SELL | Equity | +100% |
| 2026-05-07 | SELL | Equity | +76% |
| 2026-05-07 | SELL | Equity | +19% |
| 2026-05-07 | SELL | Equity | +12% |
| 2026-05-07 | SELL | Equity | +0% |
| 2026-05-07 | SELL | Equity | +5% |
| 2026-05-06 | SELL | Equity | +1% |
| 2026-05-05 | SELL | Equity | +43% |
| 2026-05-05 | SELL | Equity | +11% |
| 2026-05-05 | SELL | Equity | +0% |
| 2026-05-05 | SELL | Equity | +6% |
| 2026-05-05 | SELL | Equity | +2% |
| 2026-04-30 | BUY | Equity | +11% |
| 2026-04-30 | BUY | Equity | +1% |
| 2026-04-29 | BUY | Equity | +22% |
| 2026-02-27 | BUY | Equity | +1% |
| 2026-02-24 | BUY | Equity | +11% |
| 2026-02-23 | BUY | Equity | +8% |
| 2026-02-23 | BUY | Equity | +8% |
| 2026-02-23 | BUY | Equity | +8% |
| 2026-02-20 | BUY | Equity | +11% |
| 2026-02-20 | BUY | Equity | +11% |
| 2026-02-20 | BUY | Equity | +22% |
| 2026-02-19 | BUY | Equity | +11% |
Notes
Full portfolio moat / asset analysis
Lemonade's claimed moat rests on proprietary AI claims processing that reduces costs and improves accuracy by ~30%. However, this technological advantage faces erosion as major incumbent insurers aggressively adopt AI. Switching costs are relatively low — customers can easily change policies annually. The mobile-first UX appeals to millennial/Gen-Z demograp…
Full portfolio moat / asset analysis
The company is targeting adjusted EBITDA profitability by Q4 2026 with 30% IFP CAGR. But Lemonade lacks the massive policyholder base and data advantage of traditional insurers.
Open the working company page.
Authenticated sessions unlock the live watchlist controls, expanded market-data views, add-note workflow, and full internal timeline.